News from Prime Therapeutics LLC A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 08, 2017, 09:10 ET Prime Therapeutics Signs Outcomes-Based Contract with Novo Nordisk for Type 2 Diabetes Drug Victoza® (liraglutide)

As the rate of diabetes continues to escalate in the United States, health care payers are looking for solutions to help manage the cost of...


Dec 01, 2017, 09:00 ET Prime Therapeutics Signs CareCentered Contract™ with leading manufacturer of Multiple Sclerosis drugs

Given the growing use and cost of multiple sclerosis (MS) medicines, Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM), and...


Oct 30, 2017, 12:17 ET Prime Therapeutics Applauds Cross-Functional Opioid Epidemic Report from Clinton Foundation and Johns Hopkins Bloomberg School of Public Health

Prime Therapeutics released the following statement from its Chief Medical Officer Jonathan Gavras, M.D.: A report titled "The Opioid Epidemic:...


Oct 23, 2017, 10:00 ET New Public Opinion Survey Finds Few Safely Dispose of Unused Medicine, Most Opioid Users Weren't Told About the Potential for Opioid Addiction

As the nation grapples with the crisis of opioid abuse and misuse, a new survey by pharmacy benefit manager Prime Therapeutics LLC (Prime) finds...


Oct 17, 2017, 09:00 ET Prime Therapeutics' Studies Examine Rheumatoid Arthritis Therapies and Total Cost

Two new studies by pharmacy benefit manager Prime Therapeutics LLC (Prime) show commercially insured members with rheumatoid arthritis (RA) had 3.5...


Oct 16, 2017, 09:00 ET Prime Therapeutics Controlled Substance Management Program Helped Decrease Opioid Use Among Those at Highest Risk

Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 20 million members nationally, examined opioid use and...


Oct 13, 2017, 11:30 ET Prime Therapeutics Study Finds a Diabetes Drugs Value Based Insurance Design Improves Adherence, Doesn't Lower Total Cost of Care

Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 20 million members nationally, found that implementing value...


Oct 12, 2017, 12:00 ET Mid-Year Drug Trend: Prime held spending increases to 0.8% for commercial clients, generated negative trend for government program clients

Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving more than 20 million members nationally, today released mid-year...


Jul 20, 2017, 17:30 ET Prime Therapeutics Urges Caution on Mandates of Abuse-Deterrent Formulations of Opioids Citing Value Concerns

Prime Therapeutics LLC (Prime) released this statement from its Chief Medical Officer, Jonathan Gavras, M.D., following today's Institute for...


Jul 17, 2017, 12:15 ET Prime Therapeutics Launches Comprehensive Program to Address Opioid and Controlled Substance Epidemic

A comprehensive program announced today by pharmacy benefit manager Prime Therapeutics LLC (Prime), which serves 14 Blue Cross and Blue Shield...


Jan 27, 2017, 08:00 ET Prime Therapeutics is Certified for NCQA Utilization Management and Health Information Products - Pharmacy Benefit Information

National Committee for Quality Assurance (NCQA) has certified Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM), in two...


Jan 06, 2017, 13:01 ET Prime Therapeutics Names Mike Kolar Senior Vice President, General Counsel

Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 22 million members nationally, has named Mike Kolar as senior...


Dec 21, 2016, 13:18 ET Prime Therapeutics fills new chief of sales position

Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 22 million members nationally, has named John Drakulich as chief...


Sep 30, 2016, 11:35 ET Prime Therapeutics Finds Autoimmune Specialty Drug Spend has Doubled, Accounts for 10 Percent of Drug Expenses

In the past four years, spending on autoimmune drugs has doubled and utilization has jumped nearly 40 percent in a population of 4.4 million...


Sep 29, 2016, 11:51 ET Prime Therapeutics Intervention Associated with Fewer High-risk Medication Refills in Medicare Population

Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving over 22 million members nationally, studied the success of its...


Sep 28, 2016, 09:00 ET PrimeTherapeutics Finds Use of Short Acting Opioids Decreased, Long Acting Opioids Increased

Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving over 22 million members nationally, analyzed pharmacy claims for both short and...


Sep 27, 2016, 12:51 ET Prime Therapeutics Research Finds Nearly Half of Members Discontinue Costly Rheumatoid Arthritis Drug After One Year

 Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving over 22 million members nationally, analyzed members' use of rheumatoid...


Sep 23, 2016, 09:00 ET Prime Therapeutics Joins ICER as Flagship Member

Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM), has joined the Institute for Clinical and Economic Review (ICER)...


Apr 19, 2016, 10:00 ET Prime Therapeutics Releases Studies on Efforts to Reduce Opioid Abuse, Misuse

Two new studies presented this week by pharmacy benefit manager Prime Therapeutics LLC (Prime) at the Academy of Managed Care Pharmacy (AMCP)...


Mar 08, 2016, 14:00 ET Prime Therapeutics to provide pharmacy benefits management to Blue Cross & Blue Shield of Rhode Island

 Prime Therapeutics LLC (Prime) announced today that it will begin managing pharmacy benefits for Blue Cross & Blue Shield of...


Dec 22, 2015, 16:42 ET Prime Therapeutics prefers both cholesterol lowering drugs Praluent® and Repatha® on its national drug list

 Prime Therapeutics LLC (Prime) announced today it will prefer on its national drug list, both Praluent® and Repatha®,...


Nov 23, 2015, 10:00 ET Prime Therapeutics and CoverMyMeds Help Lower the Number of High-Risk Medication Prescriptions for Seniors

Medicare beneficiaries were 57 percent less likely to receive prescriptions that may cause potential health risks as a result of a pilot program...


Oct 26, 2015, 14:00 ET Prime Therapeutics' studies find cholesterol-lowering statins are underused

 Nationally, approximately half of patients prescribed statins as a cholesterol lowering therapy discontinue use within the first year, and...


Oct 26, 2015, 14:00 ET Prime finds breast cancer drug Ibrance taking off, signaling importance of care management

As costly, six-figure drugs continue to gain approval by Food and Drug Administration (FDA), the need for analysis and understanding of...


Oct 26, 2015, 14:00 ET New study: Prime Therapeutics' Medication Therapy Management program increases number of adherent Medicare members

 Prime Therapeutics' LLC (Prime) researchers found up to a 40 percent higher proportion of adherent Medicare members...